QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
OTCMKTS:PVCT

Provectus Biopharmaceuticals - PVCT Short Interest Ratio & Short Volume

$0.13
0.00 (0.00%)
(As of 01/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.13
$0.13
50-Day Range
$0.06
$0.18
52-Week Range
$0.03
$0.19
Volume
121,846 shs
Average Volume
209,587 shs
Market Capitalization
$53.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Provectus Biopharmaceuticals Short Interest Data

Current Short Volume
9,700 shares
Previous Short Volume
100 shares
Change Vs. Previous Month
+9,600.00%
Dollar Volume Sold Short
$1,286.71
Short Interest Ratio / Days to Cover
0.0
Last Record Date
January 15, 2023
Outstanding Shares
419,497,000 shares
Percentage of Shares Shorted
0.00%
Today's Trading Volume
121,846 shares
Average Trading Volume
209,587 shares
Today's Volume Vs. Average
-41.86%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Provectus Biopharmaceuticals ?

Sign up to receive the latest short interest report for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PVCT Short Interest Over Time

PVCT Days to Cover Over Time

PVCT Percentage of Float Shorted Over Time


Provectus Biopharmaceuticals (OTCMKTS:PVCT) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/15/20239,700 shares $1,286.71 +9,600.0%N/A0 $0.13
12/30/2022100 shares $10.83 -99.0%N/A0 $0.11
12/15/202210,000 shares $1,099.00 -66.6%N/A0 $0.11
11/30/202229,900 shares $2,780.70 -45.5%N/A0 $0.09
11/15/202254,900 shares $2,843.82 +54,800.0%N/A0.1 $0.05
10/31/2022100 shares $5.00 No ChangeN/A0 $0.05
10/15/2022100 shares $4.85 No ChangeN/A0 $0.05
9/30/2022100 shares $4.90 -99.6%N/A0 $0.05
9/15/202225,500 shares $1,351.50 +8.5%N/A0.1 $0.05
8/31/202223,500 shares $1,280.75 +2,511.1%N/A0.1 $0.05
8/15/2022900 shares $49.50 +80.0%N/A0 $0.06
7/31/2022500 shares $29.00 +400.0%N/A0 $0.06
7/15/2022100 shares $5.99 -99.6%N/A0 $0.06
6/30/202226,200 shares $1,419.28 +26,100.0%N/A0.1 $0.05
6/15/2022100 shares $5.30 -96.8%N/A0 $0.05
5/31/20223,100 shares $186.00 -54.4%N/A0 $0.06
5/15/20226,800 shares $357.68 +3,300.0%N/A0 $0.05
4/30/2022200 shares $12.28 +100.0%N/A0 $0.06
4/15/2022100 shares $5.86 No ChangeN/A0 $0.06
3/31/2022100 shares $6.74 No ChangeN/A0 $0.07
3/15/2022100 shares $6.92 -96.7%N/A0 $0.07
2/28/20223,000 shares $206.70 +2,900.0%N/A0 $0.07
2/15/2022100 shares $7.00 -98.7%N/A0 $0.07
1/31/20227,700 shares $500.50 -85.4%N/A0 $0.07
1/15/202252,600 shares $3,682.00 +39.2%N/A0.1 $0.07
12/31/202137,800 shares $2,079.00 +37,700.0%N/A0 $0.06
12/15/2021100 shares $5.03 -93.8%N/A0 $0.05
11/30/20211,600 shares $85.76 -61.0%N/A0 $0.05
11/15/20214,100 shares $213.61 +4,000.0%N/A0 $0.05
10/29/2021100 shares $5.62 -99.9%N/A0 $0.06
10/15/202190,700 shares $5,587.12 -24.6%N/A0.4 $0.06
9/30/2021120,300 shares $7,819.50 +55.8%N/A0.3 $0.07
9/15/202177,200 shares $4,863.60 -45.4%N/A0.2 $0.06
8/31/2021141,300 shares $8,619.30 -29.4%N/A0.1 $0.06
8/13/2021200,200 shares $13,913.90 -22.3%N/A0.5 $0.07
7/30/2021257,500 shares $17,896.25 +29.7%N/A1 $0.07
7/15/2021198,600 shares $13,902.00 +13.6%N/A0.4 $0.07
6/30/2021174,900 shares $11,980.65 -3.6%N/A0.7 $0.07
6/15/2021181,500 shares $12,668.70 -10.4%N/A0.3 $0.07
5/28/2021202,600 shares $14,911.36 +9.0%N/A0.5 $0.07













PVCT Short Interest - Frequently Asked Questions

What is Provectus Biopharmaceuticals' current short interest?

Short interest is the volume of Provectus Biopharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of January 15th, traders have sold 9,700 shares of PVCT short. Learn More on Provectus Biopharmaceuticals' current short interest.

Is Provectus Biopharmaceuticals' short interest increasing or decreasing?

Provectus Biopharmaceuticals saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 9,700 shares, an increase of 9,600.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Provectus Biopharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Provectus Biopharmaceuticals: Bolt Biotherapeutics, Inc. (7.22%), SCYNEXIS, Inc. (2.85%), Hepion Pharmaceuticals, Inc. (0.73%), Infinity Pharmaceuticals, Inc. (1.32%), Applied Therapeutics, Inc. (0.44%), Pyxis Oncology, Inc. (4.10%), Unity Biotechnology, Inc. (3.99%), Bioxytran, Inc. (0.02%), Lantern Pharma Inc. (2.01%), and Alzamend Neuro, Inc. (4.54%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.43 billion), T. Rowe Price Group, Inc. ($2.26 billion), Coinbase Global, Inc. ($2.19 billion), Etsy, Inc. ($1.78 billion), Paramount Global ($1.77 billion), Old Dominion Freight Line, Inc. ($1.69 billion), United Rentals, Inc. ($1.53 billion), American Airlines Group Inc. ($1.52 billion), PG&E Co. ($1.48 billion), and Voya Financial, Inc. ($1.47 billion). View all of the most shorted stocks.

What does it mean to sell short Provectus Biopharmaceuticals stock?

Short selling PVCT is an investing strategy that aims to generate trading profit from Provectus Biopharmaceuticals as its price is falling. PVCT shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Provectus Biopharmaceuticals?

A short squeeze for Provectus Biopharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PVCT, which in turn drives the price of the stock up even further.

How often is Provectus Biopharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PVCT, twice per month. The most recent reporting period available is January, 15 2023.



This page (OTCMKTS:PVCT) was last updated on 1/31/2023 by MarketBeat.com Staff